Skip to main content
Journal cover image

Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.

Publication ,  Journal Article
Ahlawat, S; Blakeley, J; Montgomery, E; Subramaniam, RM; Belzberg, A; Fayad, LM
Published in: Skeletal Radiol
September 2013

Neurofibromatosis type 1 (NF1) is a neurocutaneous syndrome characterized by the development of multiple peripheral nerve sheath tumors, the majority of which are benign neurofibromas. However, malignant peripheral nerve sheath tumors (MPNSTs) occur with a 10 % lifetime risk in patients with NF1, often developing within a neurofibroma. When clinical suspicion for an MPNST arises, imaging with FDG PET and MRI is performed to characterize a peripheral tumor for potential malignancy. In this report, we describe a patient with NF-1 who had two peripheral tumors with similar features by PET, both suspicious for MPNST, but differing features by MRI, one of which was subsequently determined to be an MPNST and the second to be a schwannoma.

Duke Scholars

Published In

Skeletal Radiol

DOI

EISSN

1432-2161

Publication Date

September 2013

Volume

42

Issue

9

Start / End Page

1317 / 1322

Location

Germany

Related Subject Headings

  • Soft Tissue Neoplasms
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neurofibromatosis 1
  • Neoplasms, Multiple Primary
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ahlawat, S., Blakeley, J., Montgomery, E., Subramaniam, R. M., Belzberg, A., & Fayad, L. M. (2013). Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. Skeletal Radiol, 42(9), 1317–1322. https://doi.org/10.1007/s00256-013-1626-3
Ahlawat, Shivani, Jaishri Blakeley, Elizabeth Montgomery, Rathan M. Subramaniam, Allan Belzberg, and Laura M. Fayad. “Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.Skeletal Radiol 42, no. 9 (September 2013): 1317–22. https://doi.org/10.1007/s00256-013-1626-3.
Ahlawat S, Blakeley J, Montgomery E, Subramaniam RM, Belzberg A, Fayad LM. Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. Skeletal Radiol. 2013 Sep;42(9):1317–22.
Ahlawat, Shivani, et al. “Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.Skeletal Radiol, vol. 42, no. 9, Sept. 2013, pp. 1317–22. Pubmed, doi:10.1007/s00256-013-1626-3.
Ahlawat S, Blakeley J, Montgomery E, Subramaniam RM, Belzberg A, Fayad LM. Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging. Skeletal Radiol. 2013 Sep;42(9):1317–1322.
Journal cover image

Published In

Skeletal Radiol

DOI

EISSN

1432-2161

Publication Date

September 2013

Volume

42

Issue

9

Start / End Page

1317 / 1322

Location

Germany

Related Subject Headings

  • Soft Tissue Neoplasms
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Nuclear Medicine & Medical Imaging
  • Neurofibromatosis 1
  • Neoplasms, Multiple Primary
  • Middle Aged
  • Male